Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACTOR fever management trial
ACTRN12616001285448Phase 2Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of acetaminophen in fever (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: Between-group difference in mean body temperature. Started Nov 2016; status: completed.
02
Drugs
acetaminophen
03
Conditions
fever
Beyond the preview
Go deeper on ACTRN12616001285448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001285448.